Danaher Corporation (DHR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Danaher Corporation (DHR:NYSE), powered by AI.

Current Price
$180.10
P/E Ratio
35.5
Market Cap
128.4B
Sector
Healthcare
What is the Danaher Corporation stock price forecast?

Danaher Corporation is currently trading at $180.10. View real-time AI analysis on Alpha Lenz.

What is Danaher Corporation insider trading activity?

View the latest insider trading data for Danaher Corporation on Alpha Lenz.

What is Danaher Corporation's P/E ratio?

Danaher Corporation's P/E ratio is 35.5.

Danaher Corporation

NYSE · DHR
$180.10-0.69(-0.38%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Danaher Corporation's future dividend policy...
Alpha Chat Insight

Danaher Corporation trades at a P/E of 35.5 (premium valuation) with modest ROE of 7.1%.

Ask for details

Company Overview

Danaher Corporation is a globally recognized science and technology company specializing in the development, design, and manufacturing of diverse industrial and healthcare products. With a primary focus on innovations in diagnostics, life sciences, dental, and environmental and applied solutions, Danaher serves a multitude of industries and market sectors. Its cutting-edge diagnostic equipment aids medical professionals in delivering precise healthcare, while its life sciences tools and technologies propel biomedical research and development. The company's environmental solutions also play a key role in enhancing water quality analysis and management. Headquartered in Washington, D.C., Danaher is renowned for its strong operational culture exemplified by the Danaher Business System (DBS), which emphasizes continuous improvement and sustainable innovation. This approach has solidified Danaher's presence and influence in both developing specialized solutions and improving efficiency across global markets. The company's strategic acquisitions and consistent focus on innovation have positioned it as a leader in delivering essential solutions that drive significant improvements for healthcare, research, and industrial clients.

CEOMr. Rainer M. Blair
SectorHealthcare
IndustryDiagnostics & Research
Employees61,000

Company Statistics

FY 2025

Profile

$128.36BMarket Cap
$24.57BRevenue
0.00Shares Out
61,000Employees

Margins

59.11%Gross
29.20%EBITDA
19.09%Operating
17.23%Pre-Tax
14.71%Net

Valuation

35.52P/E
2.44P/B
5.22EV/Sales
20.00EV/EBITDA
24.40P/FCF

Growth (CAGR)

-2.67%Rev 3Yr
1.97%Rev 5Yr
-14.62%Op Inc 3Yr
2.08%Op Inc 5Yr
-20.56%Net Inc 3Yr
-0.18%Net Inc 5Yr

Returns

4.49%ROA
7.08%ROE
5.59%ROIC

Financial Health

$4.62BCash & Cash Equivalents
$26.31BNet Debt
58.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Danaher Corporation (ticker: DHR) is a company listed on NYSE in the Healthcare sector (Diagnostics & Research). It has approximately 61,000 employees. Market cap is $128.4B.

The current price is $180.1 with a P/E ratio of 35.52x and P/B of 2.44x.

ROE is 7.08% and operating margin is 19.09%. Annual revenue is $24.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Danaher Corporation (DHR) Stock Forecast 2026 $180.10 — Price, Financials & Analyst Targets | Alpha Lenz